Home › Research › How common it is
A multinational cohort study of trends in survival following dementia diagnosis
Hao Luo, Marjaana Koponen, Christoph Roethlein, Cornelia Becker, J. Simon Bell, Kebede Abera Beyene, Yi Chai, Amy Hai Yan Chan et al.. Communications Medicine, 2025-05-28
Topic: Risk, prevention and care in population studies
Plain-language summary
Data from 1,272,495 individuals, with the mean age at diagnosis ranging from 76.8 years (South Korea) to 82.9 years (Germany), show that the overall median length of survival following recorded diagnosis ranges from 2.4 years (New Zealand) to 7.9 years (South Korea). In five of these regions, people diagnosed with dementia in more recent years had a lower risk of dying compared to those diagnosed in earlier years.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 1,272,495 participants. This multinational cohort study found that median survival after dementia diagnosis ranged from 2.4 to 7.9 years across regions, and in five regions people diagnosed more recently had a lower risk of dying. It describes survival trends and does not test any treatment, cure, or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Luo, H., Koponen, M., Roethlein, C., Becker, C., Bell, J. S., Beyene, K. A., et al. (2025). A multinational cohort study of trends in survival following dementia diagnosis. Communications Medicine. https://doi.org/10.1038/s43856-025-00923-6
Vancouver
Luo H, Koponen M, Roethlein C, Becker C, Bell JS, Beyene KA, et al. A multinational cohort study of trends in survival following dementia diagnosis. Communications Medicine. 2025. doi:10.1038/s43856-025-00923-6. PMID: 40437158.
BibTeX
@article{luo2025-40437158,
author = {Luo, Hao and Koponen, Marjaana and Roethlein, Christoph and Becker, Cornelia and Bell, J. Simon and Beyene, Kebede Abera and Chai, Yi and Chan, Amy Hai Yan and others},
title = {{A multinational cohort study of trends in survival following dementia diagnosis}},
journal = {Communications Medicine},
year = {2025},
doi = {10.1038/s43856-025-00923-6},
pmid = {40437158},
url = {https://doi.org/10.1038/s43856-025-00923-6}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Data from 1,272,495 individuals, with the mean age at diagnosis ranging from 76.8 years (South Korea) to 82.9 years (Germany), show that the overall median length of survival following recorded diagnosis ranges from 2.4 years (New Zealand) to 7.9 years (South Korea).
- In five of these regions, people diagnosed with dementia in more recent years had a lower risk of dying compared to those diagnosed in earlier years.
Why it matters
This multinational cohort study found that median survival after dementia diagnosis ranged from 2.4 to 7.9 years across regions, and in five regions people diagnosed more recently had a lower risk of dying. It describes survival trends and does not test any treatment, cure, or prevention.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Study designcohort study
- Participants1,272,495
- Evidence strengthModerate
How this study scored 57/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Communications Medicine) |
| Journal's citation record | 0 / 4 | Communications Medicine: journal h-index 55 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 4 / 4 | 1,272,495 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 8 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 5.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 8 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Ian Chi Kei Wong: h-index 85 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University College London: institution h-index 2,029 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 20 institution(s) in 10 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40437158) |
| Free to read | 2 / 2 | Free to read |
| Total | 57 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1038/s43856-025-00923-6
- PubMed: 40437158
- Original source →
- Free full text: Communications Medicine →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in How common it is from nearby years
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.